Mercer Global Advisors’s iRadimed IRMD Stock Holding History

Mercer Global Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$759K	Buy	+7,940	New	+$723K	﹤0.01%	1963

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mercer Global Advisors's IRMD Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in iRadimed (IRMD) in Q2 2026: 7,940 shares worth $759K. The stake represents ﹤0.01% of the portfolio and ranks #1963 among its holdings.

214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Mercer Global Advisors held 7,940 shares of iRadimed worth $759K as of Q2 2026.
iRadimed was a new Mercer Global Advisors position in Q2 2026.
iRadimed made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1963 holding.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.